Category


Years
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 1 - 50 of 3494.
1 2 3 4 5 ... 70 Next »

Medicine/Pharmacology - Life Sciences
23.06.2017
Chinese investment in biomedical research
Cardiff University is joining forces with a major Chinese biomedical service provider to explore key biomedical and clinical research opportunities.
Medicine/Pharmacology - Life Sciences
23.06.2017
NEJM publishes full analysis of Rydapt (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
Significant overall survival benefit observed for FLT3+ AML patients consistent across FLT3 mutation subgroups, including ITD and TKD Detailed data show Rydapt plus standard chemotherapy improved eve
History/Archeology
23.06.2017
Book reveals how Enlightenment thinkers saw Europe
A new book shows how the great European thinkers of the Enlightenment approached the question of Europe's political and economic future.
Philosophy - Business/Economics
23.06.2017
‘Programmers should not decide who lives and who dies'
‘Programmers should not decide who lives and who dies’
Research news What and how will tomorrow's self-driving cars be allowed to decide for themselves' Tasked by the German government, an ethics commission has now drawn up guidelines to regulate these questions.
Medicine/Pharmacology - Life Sciences
23.06.2017
Treating antibiotic-resistant TB
A newly discovered antibiotic, produced by bacteria from a cystic fibrosis patient, could be used to treat cases of drug-resistant tuberculosis (TB). This is the finding of a team of scientists from Cardiff University's School of Biosciences and the University of Warwick. The problem of antibiotic-resistant infections is well documented, and it is estimated that by 2040, more than a third of all TB cases in Russia, for example, could show resistance to the drugs currently used to fight the disease.
Medicine/Pharmacology - Physics/Materials Science
23.06.2017
How to train your drugs: from nanotherapeutics to nanobots
How to train your drugs: from nanotherapeutics to nanobots
Nanotechnology is creating new opportunities for fighting disease - from delivering drugs in smart packaging to nanobots powered by the world's tiniest engines.
Business/Economics - Agronomy/Food Science
23.06.2017
N.Y. honeybees stung hard by varroa mite, researchers find
A small mite is causing big trouble for New York's honeybee population and putting in peril the fruit and vegetable crops that depend on these pollinators. Other beekeeper team findings ‘ A study of 30 apple orchards revealed a high level of pesticide exposure (five acute cases, 22 chronic). The majority of the high-risk insecticides appear to be coming not from the apples or the pollen that bees are collecting from the apples, but from wildflowers surrounding the orchards, which points to a potential issue in grower spray practices.
Physics/Materials Science - Mechanical Engineering/Mechanics
23.06.2017
Atomic imperfections move quantum communication network closer to reality
An international team led by the University of Chicago's Institute for Molecular Engineering has discovered how to manipulate a weird quantum interface between light and matter in silicon carbide along wavelengths used in telecommunications.
Environment/Sustainable Development
23.06.2017
Pioneering community energy pilot underway at Nottingham housing development
The Energy Research Accelerator (ERA) and the University of Nottingham are leading an innovative community energy initiative which could become the model for introducing low-carbon energy solutions at residential developments across the UK.
Careers/Employment - Mechanical Engineering/Mechanics
23.06.2017
Imperial early-career researcher recognised in prestigious list
Imperial early-career researcher recognised in prestigious list
An Imperial engineer has been nominated as one of the top 50 women in engineering. Dr Nan Li, from the Dyson School of Design Engineering at Imperial College London, has been chosen by a panel of experts as one of the top women under 35 in engineering.
Computer Science/Telecom
23.06.2017
CIS researchers receive $2.5M NSF grant for cybersecurity
Four Cornell computer science researchers will receive $2.5 million from the National Science Foundation to develop software tools that will improve cybersecurity.
Computer Science/Telecom - Microtechnics/Electroengineering
23.06.2017
Carnegie Mellon’s RoboTutor Advances to Global Learning XPRIZE Semifinals
By Shilo Rea RoboTutor , technology developed at Carnegie Mellon University that teaches children basic math and reading skills, has been named a semifinalist in the $15 million Global Learning XPRIZE competition.
Medicine/Pharmacology - Veterinary Science
23.06.2017
Dog’s leg saved from amputation by new bone regeneration technology
Scientists and veterinarians from the University of Glasgow have successfully saved the leg of a two-year-old Munsterlander dog named Eva from amputation using medical technology funded by Sir Bobby
Religions
23.06.2017
The religious lives of international seafarers
The religious and spiritual experiences of seafarers, and ministry amongst port chaplains, will be explored in a new project by Cardiff University's Seafarers International Research Centre (SIRC).
Politics - Social Sciences
23.06.2017
Brexit gives rise to new political identities, new report finds
Brexit gives rise to new political identities, new report finds
Two academics from Queen Mary University of London (QMUL) have contributed to a report on the challenges and implications of Brexit a year after the vote.
Medicine/Pharmacology - Life Sciences
23.06.2017
Novartis Kisqali (ribociclib) receives positive CHMP opinion as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor
Novartis Kisqali (ribociclib) receives positive CHMP opinion as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor CHMP opinio
Agronomy/Food Science - Life Sciences
23.06.2017
Cornell to team with IBM to protect global milk supply
Cornell and IBM announced a joint research project June 23 that will use genetic sequencing and big-data analyses to help keep the global milk supply safe.
Computer Science/Telecom - Careers/Employment
23.06.2017
Calling all women: London's tech sector needs you!
Calling all women: London’s tech sector needs you!
An Imperial computer engineering expert talks about the problems the UK's tech sector faces in the future if it doesn't address a gender imbalance.
Astronomy - Environment/Sustainable Development
23.06.2017
Le Bourget Day 4
Le Bourget Day 4
France Sentinel-3 gives us a nearly cloud-free view of France and the surrounding countries. Much of the landscape is covered with agricultural features.
Computer Science/Telecom - Microtechnics/Electroengineering
23.06.2017
Return of the Robots: Imperial revs up for nationwide UK Robotics Week 2017
Return of the Robots: Imperial revs up for nationwide UK Robotics Week 2017
Imperial will join 17 UK universities to showcase its world-leading robotics innovations from 24 to 30 June.
Computer Science/Telecom - Politics
23.06.2017
Tackling the threat of cyber-security
Cardiff and Coventry universities have joined forces to help ensure the UK is primed to respond to policy challenges posed by the ever-growing threat of cyber-attacks.
Medicine/Pharmacology - Life Sciences
23.06.2017
Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL
83% of patients achieved complete remission (CR) or CR with incomplete blood count recovery within 3 months of treatment with CTL019; consistent with interim ELIANA data   Data evaluating 63 patients demonstrate relapse-free survival and probability of survival in a majority of patients at six months   Advances in CTL019 and ELIANA result from global CAR-T cell therapy collaboration with the University of Pennsylvania   CTL019 is manufactured us
Medicine/Pharmacology - Chemistry
23.06.2017
Novartis data shows half of eligible Ph+ CML-CP patients remain in Treatment-free Remission nearly two years after stopping Tasigna
New 96-week data support durability and safety of Treatment-free Remission (TFR) in Ph+ CML-CP patients who stop taking Tasigna [1,2] More than 90% of Ph+ CML-CP patients in ENESTfreedom and ENESTop who stopped Tasigna and were in TFR at 48 weeks remained in TFR at 96 weeks [1,2] 48-week data from same trials recently added to Tasigna SmPC following EC approval; discussions with other regulatory authorities are underway worldwide - Novartis toda
Psychology
23.06.2017
Program helps stressed teens shake it off
Program helps stressed teens shake it off
For high school students suffering from academic anxiety, Taylor Swift or Kanye West might be just what they need to alleviate stress.
Astronomy - Chemistry
23.06.2017
UCL's first satellite ‘UCLSat' launched
UCL’s first satellite ‘UCLSat’ launched
UCLSat, a satellite designed and built by UCL engineers and scientists, has been launched today from the Satish Dhawan Space Centre in India as part of an international mission called QB50.
Medicine/Pharmacology
23.06.2017
Guided self-help approach to graded exercise programme is safe and may reduce fatigue for patients with chronic fatigue syndrome
Guided self-help approach to graded exercise programme is safe and may reduce fatigue for patients with chronic fatigue syndrome
A self-help approach to a graded exercise programme, supervised by a specialist physiotherapist, is safe and may reduce fatigue for some people with chronic fatigue syndrome (CFS), according to a new trial of 200 people published in The Lancet .
Medicine/Pharmacology - Life Sciences
23.06.2017
Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain patients with high-risk chronic lymphocytic leukaemia and its potential in other hard-to-treat blood cancers
Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain patients with high-risk chronic lymphocytic leukaemia and its potential in other hard-to-treat blood cancers First in class BCL2-specific oral inhibitor represents a potential new way of treating different blood cancers Efficacy and tolerability confirmed in high-risk patients with relapsed or refractory chronic lymphocytic leukaemia, including those with 17p chromosomal de
Arts and Design
23.06.2017
Indigenous composers record new works at ANU
Emerging Indigenous composers from around Australia have recorded a series of new compositions at ANU under a new mentoring program run out of the ANU School of Music.
Astronomy
23.06.2017
ANU opens lodge at Siding Spring Observatory
Fire can destroy buildings but the discoveries made by the great academics at ANU, who work with telescopes at Siding Spring Observatory, can never be deleted from the global understanding of astronomy, astrophysics and space science.
Medicine/Pharmacology - Physics/Materials Science
23.06.2017
Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma
Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma Longer follow-up showed sustained benefit in progression-free survival of Gazyva/Gazyvaro-based treatment over MabThera/Rituxan-based treatment regardless of chemotherapy regimens People with follicular lymphoma who received Gazyva/Gazyvaro-based treatment reported improvement in health-related qualit
Administration/Government
23.06.2017
Medicine/Pharmacology - Life Sciences
23.06.2017
FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers
FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers Treatment can be administered in five to seven minutes, compared to 1.5 hour
Medicine/Pharmacology - Life Sciences
23.06.2017
Novartis combination targeted therapy Tafinlar + Mekinist receives FDA approval for BRAF V600E mutant metastatic non-small cell lung cancer (NSCLC)
Novartis combination targeted therapy Tafinlar + Mekinist receives FDA approval for BRAF V600E mutant metastatic non-small cell lung cancer (NSCLC) Approval provides first targeted treatment in the U
Arts and Design - Astronomy
23.06.2017
Music from above and below
Over two nights, two dramatic Brisbane landmarks will host an immersive double-concert experience. To the earth // To the sky is the latest creative performance by University of Queensland music PhD student Connor D'Netto – operating as Argo.
Computer Science/Telecom - History/Archeology
22.06.2017
Online hillforts atlas maps all 4,147 in Britain and Ireland for the first time
Dotted across the landscape of Britain and Ireland, hillforts have been part of our story for millennia and for the first time a new online atlas launched today captures all of their locations and key details in one place. A research team based at the universities of Oxford, Edinburgh and University College Cork has been helped by citizen scientists from across England, Wales, Northern Ireland, Scotland and Ireland.
Medicine/Pharmacology - Sport Sciences
22.06.2017
Inspirational Stanford athlete Tyrone McGraw dies at 29
T YRONE McGRAW made me see the world differently. While working on a feature story on McGraw, a two-sport athlete in track and football at Stanford, I described him as a rare success story out of San Francisco's tough Bayview-Hunters Point.
Media
22.06.2017
Supporting young journalists
The Sue Lloyd Roberts Scholarship – designed to support the training of young journalists at Cardiff University's School of Journalism, Media and Cultural Studies – has received a £50,000 donation from the BBC.
Physics/Materials Science
22.06.2017
Engineers to develop radiation detection prototype
Engineers to develop radiation detection prototype
A prototype detector that will be able to help identify radioactive leaks around major nuclear sites is to be developed by Lancaster engineers and commercial partners.
Life Sciences - Mathematics
22.06.2017
How eggs got their shapes
The evolution of the amniotic egg - complete with membrane and shell - was key to vertebrates leaving the oceans and colonizing the land and air. Now, 360 million years later, bird eggs come in all shapes and sizes, from the almost perfectly spherical eggs of brown hawkowls to the tear-drop shape of sandpipers' eggs.  The question is, how and why did this diversity in shape evolve? The answer to that question may help explain how birds evolved and solve an old mystery in natural history.
Medicine/Pharmacology - Life Sciences
22.06.2017
U.S. drug policy needs a dose of neuroscience
Legal and illegal drugs are killing more people than AIDS ever did, yet the nation's drug policies are based on unproven assumptions about addiction.
Life Sciences - Medicine/Pharmacology
22.06.2017
Study Sheds Light on How Bacterial Organelles Assemble
Study Sheds Light on How Bacterial Organelles Assemble
Scientists are providing the clearest view yet of an intact bacterial microcompartment, revealing at atomic-level resolution the structure and assembly of the organelle's protein shell. The work, led by scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and Michigan State University (MSU), will appear in the June 23 issue of the journal Science .
Medicine/Pharmacology - Computer Science/Telecom
22.06.2017
Smell Something, Say Something
Smell PGH App Helps Pittsburghers Report Foul Odors By Byron Spice Researchers at Carnegie Mellon University's CREATE Lab are rolling out new features in Smell PGH, a smartphone app that helps Pittsb
Environment/Sustainable Development - Medicine/Pharmacology
22.06.2017
On California, the drought and the 'yuck factor'
On California, the drought and the ’yuck factor’
!- Start of DoubleClick Floodlight Tag: Please do not remove Activity name of this tag: UCB001CP Retargeting URL of the webpage where the tag is expected to be placed: http://unknown This tag must be
Astronomy
22.06.2017
Future launchers
ESA Space in Videos ESA Web-TV Satellites from European institutions will play a major role during the exploitation of the new family of ESA-developed launchers, Vega-C and Ariane 6.
Medicine/Pharmacology - Life Sciences
22.06.2017
Custom built molecule shows promise as anti-cancer therapy
Custom built molecule shows promise as anti-cancer therapy
Scientists at the University of Bath funded by Cancer Research UK have custom-built a molecule which stops breast cancer cells from multiplying in laboratory trials, and hope it will eventually lead to a treatment for the disease. But perhaps even more importantly the method they used to create the molecule has potential to be applied to develop new treatments for a wide range of cancers and other diseases.
Veterinary Science - Life Sciences
22.06.2017
University closes non-approved facility for laboratory mice: By order of the local Veterinary Office after tip-off from within Faculty / Rector: "We are appalled at this breach of trust"
The Faculty of Medicine at the University of Münster has, by order of the local Veterinary Office, closed with immediate effect a non-approved facility for laboratory mice at one of the Faculty's institutes.
Life Sciences - Event
22.06.2017
£2 million award will advance understanding of mechanisms of learning and memory
£2 million award will advance understanding of mechanisms of learning and memory
Neuroscientists at the University of Bristol have been awarded a prestigious £2 million Wellcome Trust Investigator Award for a five-year study to investigate the neuronal circuits that drive our recognition memory.
Computer Science/Telecom - Event
22.06.2017
Medicine/Pharmacology - Life Sciences
22.06.2017
Computer-designed antibodies target toxins associated with Alzheimer's disease
Computer-designed antibodies target toxins associated with Alzheimer’s disease
Researchers at the University of Cambridge have designed antibodies that target the protein deposits in the brain associated with Alzheimer's disease, and stop their production.  If we can find better and cheaper ways of producing antibodies, we would increase the chances of finding treatments for patients Michele Vendruscolo The researchers used computer-based methods to develop antibodies - the star players of the body's natural defence system - to target the deposits of misfolded proteins which are a hallmark of Alzheimer's disease.
1 2 3 4 5 ... 70 Next »